Date Title  
Dec 30, 2019
Summary ToggleSol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne Vulgaris
 
Nov 13, 2019
Summary ToggleSol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update
 
Oct 16, 2019
Summary ToggleSol-Gel to Present on Potential of Sol-Gel Microencapsulation Technology in Rosacea at 39th Annual Fall Clinical Dermatology Conference
 
Aug 13, 2019
Summary ToggleSol-Gel Technologies Reports Second Quarter 2019 Financial Results and Corporate Update
 
Aug 08, 2019
Summary ToggleSol-Gel Announces Pricing of Public Offering of Ordinary Shares
 
Jul 25, 2019
Summary ToggleSol-Gel Technologies Hosting Analyst & Investor Day
 
Jul 08, 2019
Summary ToggleSol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea
 
Jun 17, 2019
Summary ToggleSol-Gel Technologies to Host Analyst & Investor Day on July 25, 2019
 
May 28, 2019
Summary ToggleSol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo
 
May 23, 2019
Summary ToggleSol-Gel to Present at Upcoming Healthcare Investor Conferences in June
 
Displaying 11 - 20 of 46 results